About CoreTissue BioEngineering
CoreTissue BioEngineering is a company based in Yokohama (Japan) founded in 2016.. CoreTissue BioEngineering has raised $3.91 million across 1 funding round from investors including NH Foods. CoreTissue BioEngineering operates in a competitive market with competitors including Moximed, Allay Therapeutics, Abanza Tecnomed, Sparta Biomedical and Jointmedica, among others.
- Headquarter Yokohama, Japan
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$3.91 M (USD)
in 1 rounds
-
Latest Funding Round
$3.91 M (USD), Series A
Nov 10, 2025
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of CoreTissue BioEngineering
CoreTissue BioEngineering has successfully raised a total of $3.91M through 1 strategic funding round. The most recent funding activity was a Series A round of $3.91 million completed in November 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series A — $3.9M
-
First Round
First Round
(10 Nov 2025)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2025 | Amount | Series A - CoreTissue BioEngineering | Valuation | NH Foods |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in CoreTissue BioEngineering
CoreTissue BioEngineering has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include NH Foods. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Meat and meat products are produced by NH Foods.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by CoreTissue BioEngineering
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - CoreTissue BioEngineering
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Coretissue Bioengineering Comparisons
Competitors of CoreTissue BioEngineering
CoreTissue BioEngineering operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moximed, Allay Therapeutics, Abanza Tecnomed, Sparta Biomedical and Jointmedica, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
A knee implant for pre-arthroplasty osteoarthritis patients is developed.
|
|
| domain | founded_year | HQ Location |
Post-surgical pain drugs are developed using non-opioid biopolymer technology.
|
|
| domain | founded_year | HQ Location |
Surgical instruments for sports medicine procedures are developed.
|
|
| domain | founded_year | HQ Location |
Synthetic cartilage platforms are developed for orthopedic surgeons.
|
|
| domain | founded_year | HQ Location |
Smart knee replacement devices matching natural anatomy are provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about CoreTissue BioEngineering
When was CoreTissue BioEngineering founded?
CoreTissue BioEngineering was founded in 2016 and raised its 1st funding round 9 years after it was founded.
Where is CoreTissue BioEngineering located?
CoreTissue BioEngineering is headquartered in Yokohama, Japan. It is registered at Yokohama, Kanagawa, Japan.
Who is the current CEO of CoreTissue BioEngineering?
Yoji Shirokura is the current CEO of CoreTissue BioEngineering.
Is CoreTissue BioEngineering a funded company?
CoreTissue BioEngineering is a funded company, having raised a total of $3.91M across 1 funding round to date. The company's 1st funding round was a Series A of $3.91M, raised on Nov 10, 2025.
What does CoreTissue BioEngineering do?
CoreTissue BioEngineering was founded in 2016 in Yokohama, Japan, within the bioengineering sector. Implantable medical devices are developed using living tissues, with a focus on artificial ligaments for anterior cruciate ligament reconstruction in the knee. Decellularized animal tissues are employed, where cellular components are removed prior to transplantation into the human body. Operations center on tissue processing and device integration for orthopedic applications.
Who are the top competitors of CoreTissue BioEngineering?
CoreTissue BioEngineering's top competitors include Moximed, Allay Therapeutics and Sparta Biomedical.
Who are CoreTissue BioEngineering's investors?
CoreTissue BioEngineering has 1 investor. Key investors include NH Foods.